301- Miner P, Wedel M, Bane B, Bradley J. An enema formulation of alicaforsen, an antisense
inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchi-
tis. Aliment Pharmacol Ther. 2004;19(3):281–6. - Greuter T, Biedermann L, Rogler G, Sauter B, Seibold F. Alicaforsen, an antisense inhibitor
of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: a case series.
United European Gastroenterol J. 2016;4(1):97–104. - Van Assche G, Rutgeerts P. Physiological basis for novel drug therapies used to treat the
inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion
molecule therapy in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol.
2005;288(2):G169–74.
16 Anti-integrin Agents in IBD: Efficacy and Risk of Complications